Diaceutics PLC (DXRX.L)

GBp 121.5

(-0.41%)

Annual Income Statements

(In GBP)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 23.69 Million 19.5 Million 13.94 Million 12.69 Million 13.44 Million 10.37 Million
Cost of Revenue 3.99 Million 5.46 Million 3.37 Million 3.36 Million 3.13 Million 3.57 Million
Gross Profit 19.7 Million 14.03 Million 10.56 Million 9.33 Million 10.31 Million 6.8 Million
Operating Expenses 22.72 Million 13.7 Million 10.25 Million 9.94 Million 8.19 Million 5.58 Million
Selling, General and Administrative Expenses 22.78 Million 13.7 Million 10.25 Million 9.94 Million 8.19 Million 5.58 Million
Research and Development Expenses - - - - 78 Thousand -
Other Expenses - - - - - -
Cost and Expenses 26.71 Million 19.17 Million 13.63 Million 13.3 Million 11.32 Million 9.16 Million
Operating Income -2.71 Million 331 Thousand 313 Thousand -610 Thousand 2.12 Million 1.21 Million
Interest Expense 66 Thousand 122 Thousand 88 Thousand 41 Thousand 222.4 Thousand 301.57 Thousand
Income Tax Expense -734 Thousand -246 Thousand -268 Thousand -1.19 Million -57.55 Thousand 244.95 Thousand
Earnings before Tax -2.48 Million 478 Thousand 293 Thousand -929 Thousand 340.32 Thousand 877.26 Thousand
Net Income -1.74 Million 724 Thousand 561 Thousand 263 Thousand 398 Thousand 632.3 Thousand
Earnings Per Share Basic -0.02 0.01 0.01 0.00 0.01 0.01
Earnings Per Share Diluted -0.02 0.01 0.01 0.00 0.01 0.01
Weighted Average Shares Outstanding 84.22 Million 84.14 Million 83.93 Million 77.53 Million 64.06 Million 69.58 Million
Weighted Average Shares Outstanding (Diluted) 84.22 Million 86.08 Million 84.94 Million 77.83 Million 64.16 Million 69.58 Million
Gross Margin 0.83 0.72 0.76 0.74 0.77 0.66
EBIT Margin 0.10 0.17 0.15 0.02 0.18 0.13
Profit Margin -0.07 0.04 0.04 0.02 0.03 0.06
EBITDA 2.35 Million 3.6 Million 2.11 Million 178 Thousand 847.58 Thousand 1.29 Million
Earnings Before Tax Margin -0.11 0.02 0.02 -0.05 0.16 0.12

Income Statement Charts